openPR Logo
Press release

Bladder Cancer Market Size | COVID-19 Impact Analysis | Forecast to 2027

07-22-2021 10:48 AM CET | Health & Medicine

Press release from: Orion Market Research

Bladder Cancer Market Size | COVID-19 Impact Analysis | Forecast

The global bladder cancer market is projected to grow at a considerable CAGR of 5.2% during the forecast period. The main cause of bladder cancer includes the consumption of tobacco products includes cigarettes, cigars, pipes, chewing tobacco, Moreover, extensive exposure to chemicals, past harmful radiation exposure, and parasitic infections are other factors that contributing to the growth of the market. Additionally, having a family history of bladder cancer, having certain changes in the genes that are linked to bladder cancer, and Past treatment with radiation therapy or certain anticancer drugs, such as cyclophosphamide or ifosfamide. The increasing prevalence of smoking and tobacco consumption has a major impact on the growth of the bladder cancer market across the globe. Changing the lifestyle of people is a significant cause of bladder cancer. Unhealthy eating activity is increasing among people, which is a major risk for bladder cancer. As per the American Lung Association, the average smoker smokes 15 cigarettes per day in the US. Similar trends can be observed in other countries of Europe and China, and Australia.

To Request a Sample of our Report on Bladder Cancer Market:

As per World Health Organization (WHO), there are 1.1 billion people consume tobacco across the globe. Smokers are 4 to 7 times more likely to develop bladder cancer than non-smokers. Bladder cancer is the tenth most common cancer across the globe. In 2018, there were 17 million new cases of bladder cancer across the globe. As per Cancer Research UK, the incidence of cancer is estimated to reach 62% during 2018-2040 across the globe. Bladder cancer is considered the fourth common cancer in men whereas it is the least common cancer in women. As per the American Cancer Society, there will be an estimated 80,470 new cases in the US in 2019. Out of this, 61,700 new cases will be associated with male and 18,770 will be associated with the female. For instance, in March 2016 the National Cancer Institute has invested $5.5 million in establishing laboratories to advance research on biomarkers and biomarker assays for several cancers. Market players can engage with these organizations so as expand their product offerings in the coming years.

Market Coverage

· The market number available for – 2021-2027

· Base year- 2020

· Forecast period- 2021-2027

Segment Covered-

· By Cancer type

· By Diagnosis Method

· By Therapy

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Key questions addressed by the report

· What is the market growth rate?

· Which segment and region dominate the market in the base year?

· Which segment and region will project the fastest growth in the market?

· How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

· Who is the leader in the market?

· How players are addressing challenges to sustain growth?

· Where is the investment opportunity?

(Get 15% Discount on Buying this Report)

A full Report of Bladder Cancer Market is Available at:

Global Bladder Cancer Market Report Segment

By Cancer type

· Transitional Cell Bladder Cancer/ Urothelial Carcinoma

· Squamous Cell Bladder Cancer

· Adenocarcinoma

· Other Rare Types (Sarcomas, Carcinoma in Situ)

By Diagnosis Method

· Cystoscopy

· Biopsy

· Urinalysis

· Urine Cytology

· Intravenous Pyelogram (Ivp)

· Other

By Therapy

· Chemotherapy

· Immunotherapy

· Radiation Therapy

· Surgery

· Other

Global Bladder Cancer Market Report Segment by Region

North America

· United States

· Canada


· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe


· India

· China

· Japan

· Rest of APAC

Rest of The World

· Latin America

· Middle East & Africa

Company Profile

· AstraZeneca PLC

· Bristol-Myers Squibb Co.

· Celgene Corp.

· Eli Lilly And Co.

· Endo International Plc

· Epocrates, Inc.

· GlaxoSmithKline Plc

· Hoffmann-La Roche Ltd.

· Johnson & Johnson Services, Inc.

· Merck & Co., Inc.

· Merck KGaA

· Novartis International AG

· Nucleix Ltd.

· Pfizer Inc.

· Spectrum Pharmaceuticals, Inc.

Reasons for Buying from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bladder Cancer Market Size | COVID-19 Impact Analysis | Forecast to 2027 here

News-ID: 2334579 • Views: 236

More Releases from Orion Market Research

Small Wind Turbine Market Size & Growth Analysis Report, 2021-2027
The global small wind turbine market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The rising number of wind energy projects is one of the major factors driving the growth of the market small wind turbine market. According to the World Wind Energy Association, 93 gigawatts of new wind turbines were added within the year 2020. To Request a Sample of our Report on
Global Electronic Nose (E-Nose) Market Size | COVID-19 Impact Analysis | Forecas …
The global Electronic Nose (E-Nose) Market system market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The key factor to drive the market growth is the growing food and beverages industries in many countries as e-nose has its wide applications such as testing the quality of food in the industry. For instance, according to Food and drink federation, UK's top three food and beverages export
Global Dental Implants and Prosthetics Market Size | COVID-19 Impact Analysis | …
The global dental implants and prosthetics market is anticipated to grow at a CAGR of around 8.8% during the forecast period (2021-2027). Many countries face a significant health burden from oral diseases, which affect people throughout their lives, causing pain, discomfort, disfigurement, and even mortality. The adoption of unhealthy lifestyles such as addiction to tobacco, alcohol and others are leading to tooth decay and this as result will be increasing
Breast Lesion Localization Market Size | COVID-19 Impact Analysis | Forecast to …
The global breast lesion localization market is anticipated to grow at a considerable CAGR of 12.5% during the forecast period (2021-2027). The market growth is attributed to the increasing prevalence of breast cancer. Breast cancer is the second most common cancer, globally. According to the WHO, breast cancer held 11.6% of new cases in all types of cancers in 2018. The incidence of breast cancer was 2.1 million in 2018,

All 5 Releases

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and